Aditya Birla Sun Life Pharma and Healthcare Fund · Regular · Growth
Aditya Birla Sun Life Mutual Fund
NAV
₹36.3000
as of 29 Sept 2026
Expense Ratio
2.28%
AUM
₹932 Cr
Lumpsum returns (CAGR)
- 1Y
- +19.53%
- 3Y
- +19.37%
- 5Y
- +13.04%
- Since Inception
- +19.54%
SIP returns (XIRR)
- 1Y
- +23.85%
- 3Y
- +15.64%
- 5Y
- +17.82%
- Since Inception
- +17.92%
What history actually did — last 7 years (Oct 2019 – Sept 2026)
A ₹5,000 monthly SIP for the last 7 years (Oct 2019 – Sept 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹7,62,077 today — ₹4,15,000 invested, 17.4% XIRR.
₹4,15,000
Invested
₹7,62,077
Value today
17.4%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 7 years (Oct 2019 – Sept 2026)
Real NAV backtest
₹1,00,000 invested 7 years ago would be ₹3,64,092 today (20.3% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Oct 2019 would still hold ₹28,78,845.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹7,62,077 in this fund vs ₹6,28,043 in the benchmark — outperformance of ₹1,34,034.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 7 years (Oct 2019 – Sept 2026) (22 Mar 2020) would be ₹3,91,164 today (3.91×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised0.94
Sharpe Ratio
+0.16
Alpha
0.18
Beta
0.93
Sortino
11.95%
Std Dev
-8.99%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 31 Aug 2026- Pharmaceuticals & Biotechnology73.27%
- Healthcare Services21.58%
- Insurance0.78%
- Chemicals & Petrochemicals0.77%
Each sector links to the mutual funds most exposed to it.
Thinking about Aditya Birla Sun Life Pharma and Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
- 1Torrent Pharmaceuticals Ltd.9.57%
- 2Sun Pharmaceutical Industries Ltd.9.19%
- 3Apollo Hospitals Enterprise Ltd.6.85%
- 4Cipla Ltd.5.16%
- 5Aurobindo Pharma Ltd.4.53%
- 6Ajanta Pharma Ltd.4.22%
- 7Sai Life Sciences Ltd.4.20%
- 8Mankind Pharma Ltd.3.41%
- 9Lupin Ltd.3.10%
- 10Abbott India Ltd.3.03%
Investment objective — in the AMC’s words
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
About This Fund
Aditya Birla Sun Life Pharma and Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by Aditya Birla Sun Life Mutual Fund. The fund has been operational for over 7 years. It manages assets worth ₹932 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE Healthcare. The current expense ratio is 2.28%.
Who Should Invest?
- •Aggressive investors comfortable with significant short-term volatility
- •Investors with a long-term horizon of 7+ years who can ride out market cycles
- •SIP investors who can benefit from rupee cost averaging during market fluctuations